Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

New robots from Alphabet’s X (probably!) won’t kill you

Meet the less Skynet-y robot.

Rakuten Today | Twitter

The last time a Google robot trounced through the snow in a video, the robot lost its job.

This one might have better luck.

At a New Economic Summit conference in Tokyo on Friday, the founder of Schaft — one of the robotics companies Google acquired three years ago and moved to its X lab in December — showed off its latest development. A short bipedal robot trotted out onstage, followed by a video showing it fielding through different obstacles courses, plodding up stairs and navigating the outdoors.

https://www.youtube.com/watch?v=iyZE0psQsX0

A rep for X (formerly Google X) claimed the presentation isn’t an announcement or indication of its product roadmap. “The team were simply delighted to have a chance to show their latest progress,” the spokesperson said. “As with all of the robotics teams that recently moved from Google to X, we’re looking at the great technology work they’ve done so far, defining some specific real-world problems in which robotics could help, and trying to frame moonshots to address them.”

Presumably Google knew this video was happening. That wasn’t the case with the last robotics video to emerge — one from Boston Dynamics, another Google robotics firm, showing off its similarly dexterous bipedal robot. As Bloomberg first reported, that video landed as Google was preparing to put Boston Dynamics on the chopping block.

Part of the reason, according to internal emails surfaced, was the concern about the reception to Boston Dynamic’s humanoid robots, particularly coupled with Google’s very powerful artificial intelligence. The Schaft robot, as you can see above, is smaller, less menacing and less likely to evoke Skynet-type concerns.

Another reason for Boston Dynamics’ exit, according to several sources, was the vacuum left by the departure of Andy Rubin, the ex-Googler who ran the nascent robotics division, called Replicant, inside the company. Oddly enough, Schaft reportedly presented during Rubin’s keynote at the Tokyo conference.

Shortly after joining Google, Schaft won the DARPA Robotics Challenge trials. But Google decided to pull the robotics unit from the competition.

This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh